On Friday, January 8, Jennifer Lentz of Eli Lilly and patient advocate Jane Perlmutter will present CTTI’s actionable, evidence-based recommendations on informed consent at the NIH Collaboratory Grand Rounds webinar.
The proposed new model for the informed consent process places the focus back where it should be: the participant. Furthermore, the consent process should be an interactive, ongoing conversation between the participant and the research investigator or staff. We encourage anyone interested in improving clinical trial quality and efficiency to attend.
Webinar Topic: The Clinical Trials Transformation Initiative’s Informed Consent Project: Recommendations and Resources
Speakers:
- Jennifer Lentz, Global Informed Consent Process Owner, Global Clinical Operations, Eli Lilly and Company
- Jane Perlmutter, PhD, Patient Advocate
Date & Time: Friday, January 8, 2016 from 1:00 – 2:00 p.m. EST
Meeting Info: CLICK HERE to view webinar login details